| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||
Net income | |||||||||||
125,162 | 406,455 | 762,648 | 642,940 | 609,811 | 499,704 | 459,641 | 12,386 | -1,948 | -263 | -1,586 | -12,500 |
Adjustments to reconcile net income to cash used in operating activities: | |||||||||||
Interest income | |||||||||||
814,464 | 968,144 | 1,054,045 | 1,017,602 | 958,617 | 867,843 | 782,063 | 78,480 | 0 | 0 | 0 | 0 |
Unrealized gains (losses) on marketable securities | |||||||||||
72,312 | -66,163 | 91,933 | -2,465 | 26,939 | -54,048 | 6,579 | 3,156 | 0 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | |||||||||||
Changes in prepaid expenses and other current assets | |||||||||||
-36,262 | -44,710 | -20,116 | 19,926 | -38,600 | -42,760 | -36 | 183,621 | 12,500 | 0 | 12,500 | -12,500 |
Changes in accounts payable and accrued expenses | |||||||||||
220,953 | 106,358 | -562 | -96,426 | 49,625 | -77,712 | -12,548 | 194,339 | 1,644 | 0 | 0 | 0 |
Changes in income taxes receivable | |||||||||||
25,416 | -18,000 | -144,000 | 172,000 | -283,000 | 253,000 | 0 | 0 | - | - | - | - |
Net cash used by operating activities | |||||||||||
-462,483 | -362,458 | -507,776 | -316,549 | -570,520 | -96,043 | -341,513 | -58,532 | -12,804 | -263 | -14,086 | 0 |
Cash flows from investing activities: | |||||||||||
The cash outflow associated with cash deposit in trust account during the period. | |||||||||||
- | 0 | 0 | 0 | - | 0 | 0 | 174,225,000 | - | 0 | 0 | 0 |
The cash outflow associated with interest income released from trust account for taxes during the period. | |||||||||||
- | -285,000 | -322,000 | -160,848 | - | 0 | 0 | 0 | - | - | - | - |
Net cash provided by (used in) investing activities | |||||||||||
135,000 | 285,000 | 322,000 | 160,848 | 450,250 | 0 | 0 | -174,225,000 | 0 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||||
Proceeds from sale of Units in Public Offering | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 0 | 169,500,000 | 0 | 0 | 0 | 0 |
Proceeds from Sponsor Loan | |||||||||||
- | - | - | 0 | - | - | - | 1,725,000 | 0 | 0 | 0 | 0 |
Proceeds from sale of Private Placement Warrants | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 0 | 4,500,000 | 0 | 0 | 0 | 0 |
Note payable borrowings | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 0 | 45,437 | 0 | 0 | 12,500 | 0 |
Advance from Sponsor | |||||||||||
- | -60,000 | 30,000 | 30,000 | 0 | 0 | 0 | 74,540 | 0 | 0 | 0 | 0 |
Payment of offering costs | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 51,726 | 312,585 | 0 | 0 | 5,000 | 0 |
Net cash provided by financing activities | |||||||||||
350,000 | 90,000 | 30,000 | 30,000 | -4,000,000 | 0 | -371,266 | 175,532,392 | 0 | 0 | 7,500 | 0 |
Increase (decrease) in cash | |||||||||||
- | - | - | -125,701 | - | - | - | 1,248,860 | -12,804 | -263 | -6,586 | 0 |
Cash paid for taxes | |||||||||||
105,000 | 180,000 | 161,402 | 160,598 | 450,000 | 0 | 0 | 0 | - | - | - | - |
Supplemental disclosure of non-cash investing and financing activities: | |||||||||||
The amount of deferred offering costs included in accrued offering costs. | |||||||||||
- | - | - | 0 | - | - | - | 51,725 | - | - | - | 5,000 |
Deferred underwriting commissions | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 0 | 7,350,000 | 0 | 0 | 0 | 0 |
Initial value of common shares subject to possible redemption | |||||||||||
- | 0 | 0 | 0 | 0 | 0 | 0 | 161,033,395 | 0 | 0 | 0 | 0 |
Change in value of common shares subject to possible redemption | |||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 |